- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05093712
Patient-Informed Educational Intervention for the Improvement of Cervical Cancer Literacy
Patient-Informed Educational Intervention to Improve Cervical Cancer Literacy
Study Overview
Status
Conditions
- Stage IB3 Cervical Cancer FIGO 2018
- Stage II Cervical Cancer FIGO 2018
- Stage IIA Cervical Cancer FIGO 2018
- Stage IIA1 Cervical Cancer FIGO 2018
- Stage IIA2 Cervical Cancer FIGO 2018
- Stage IIB Cervical Cancer FIGO 2018
- Stage III Cervical Cancer FIGO 2018
- Stage IIIA Cervical Cancer FIGO 2018
- Stage IIIB Cervical Cancer FIGO 2018
- Stage IIIC Cervical Cancer FIGO 2018
- Stage IIIC1 Cervical Cancer FIGO 2018
- Stage IIIC2 Cervical Cancer FIGO 2018
- Stage IVA Cervical Cancer FIGO 2018
- Stage IB Cervical Cancer FIGO 2018
- Stage IB2 Cervical Cancer FIGO 2018
- Stage IB1 Cervical Cancer FIGO 2018
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVES:
I. To assess the baseline health literacy, cervical cancer knowledge and radiation knowledge in a diverse sample of patients from two hospitals in Houston, Texas. (Phase 1) II. To test improvement in comprehension of cervical cancer and radiation terminology in a diverse sample of cervical cancer patients after viewing the video-based educational tool developed in this study. (Phase 2)
SECONDARY OBJECTIVES:
I. To assess barriers to care and assess baseline radiation adherence, defined as missing no treatments and time to radiation completion, in a diverse sample of patients from two hospitals in Houston, Texas.
II. To describe the impact of the video on radiation treatment adherence in terms of radiation completion, defined as missing no treatments) and time to radiation completion.
III. To describe the relationships between time to radiation completion, health literacy, sociodemographics, reported barriers to care, and baseline cervical cancer knowledge and misconceptions.
OUTLINE:
PHASE I: Patients complete surveys over 10 minutes on their background, health literacy level, barriers to cancer care, and knowledge of cervical cancer and its treatment.
PHASE II: Patients watch educational video on cervical cancer. Patients also complete surveys over 5-10 minutes at baseline and after watching educational video.
Study Type
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Biopsy proven carcinoma of the cervix
- Federation of Gynecology and Obstetrics (FIGO) stage IB-IVA
- N0 and N1 nodal status according to TNM staging
- Planned for definitive chemoradiation with curative intent
- Able to speak and read English or Spanish
- Age 18 or older
- Able to give informed consent
Exclusion Criteria:
- Physicians or nurses
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Phase I (survey)
Patients complete surveys over 10 minutes on their background, health literacy level, barriers to cancer care, and knowledge of cervical cancer and its treatment.
|
Complete surveys
|
|
Phase II (survey, educational video)
Patients watch educational video on cervical cancer.
Patients also complete surveys over 5-10 minutes at baseline and after watching educational video.
|
Complete surveys
Watch educational video
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health literacy (Phase I)
Time Frame: Baseline
|
The proportion of patients answering a particular knowledge item correctly will be calculated along with 95% score confidence intervals.
As part of a secondary set of analyses, the percent of knowledge items answered correctly will be tabulated for each participant.
Descriptive statistics and 95% confidence intervals will be calculated for percent of items answered correctly, both by site and combining data from both sites.
|
Baseline
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-1269 (OTHER: M D Anderson Cancer Center)
- NCI-2021-10696 (REGISTRY: CTRP (Clinical Trial Reporting Program))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.